BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Liu Q, Li Z, Zhang R, Jia C, Yang Z, Zhao H, Ya S, Mao R, Ailijiang T, Bao Y, Zhang H. GP73 promotes epithelial–mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Carcinogenesis 2018;39:900-10. [DOI: 10.1093/carcin/bgy010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Loosen SH, Halpaap J, Labuhn S, Bednarsch J, Alizai PH, Roeth AA, Lang SA, Vucur M, Kather JN, Knoefel WT, Ulmer TF, Neumann UP, Roderburg C, Luedde T. Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer. Cancers 2022;14:4428. [DOI: 10.3390/cancers14184428] [Reference Citation Analysis]
2 Nagaraj M, Höring M, Ahonen MA, Nguyen VD, Zhou Y, Vihinen H, Jokitalo E, Liebisch G, Nidhina Haridas P, Olkkonen VM. GOLM1 depletion modifies cellular sphingolipid metabolism and adversely affects cell growth. Journal of Lipid Research 2022. [DOI: 10.1016/j.jlr.2022.100259] [Reference Citation Analysis]
3 Spano D, Colanzi A. Golgi Complex: A Signaling Hub in Cancer. Cells 2022;11:1990. [DOI: 10.3390/cells11131990] [Reference Citation Analysis]
4 Liu M, Huang L, Wu J, Zhang H, Ai W, Zhang R. Possible roles of Golgi protein-73 in liver diseases. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100720] [Reference Citation Analysis]
5 Wang J, Wei B, Thakur K, Wang CY, Li KX, Wei ZJ. Transcriptome Analysis Reveals the Anti-cancerous Mechanism of Licochalcone A on Human Hepatoma Cell HepG2. Front Nutr 2021;8:807574. [PMID: 34988109 DOI: 10.3389/fnut.2021.807574] [Reference Citation Analysis]
6 Liu Y, Hu X, Liu S, Zhou S, Chen Z, Jin H. Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer. Front Oncol 2021;11:783860. [PMID: 34950590 DOI: 10.3389/fonc.2021.783860] [Reference Citation Analysis]
7 Xie L, Yi J, Song Y, Zhao M, Fan L, Zhao L. Suppression of GOLM1 by EGCG through HGF/HGFR/AKT/GSK-3β/β-catenin/c-Myc signaling pathway inhibits cell migration of MDA-MB-231. Food Chem Toxicol 2021;157:112574. [PMID: 34536514 DOI: 10.1016/j.fct.2021.112574] [Reference Citation Analysis]
8 Sabbadini F, Bertolini M, Matteis S, De Mangiameli D, Contarelli S, Pietrobono S, Melisi D. The Multifaceted Role of TGF- β in Gastrointestinal Tumors.Cancers (Basel). 2021;13:3960. [DOI: 10.3390/cancers13163960] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Shrestha R, Prithviraj P, Bridle KR, Crawford DHG, Jayachandran A. Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib Treatment. J Clin Med 2021;10:1889. [PMID: 33925488 DOI: 10.3390/jcm10091889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wang SM, Yang PW, Feng XJ, Zhu YW, Qiu FJ, Hu XD, Zhang SH. Apigenin Inhibits the Growth of Hepatocellular Carcinoma Cells by Affecting the Expression of microRNA Transcriptome. Front Oncol 2021;11:657665. [PMID: 33959508 DOI: 10.3389/fonc.2021.657665] [Reference Citation Analysis]
11 Yang S, Zhang H, Yang H, Zhang J, Wang J, Luo T, Jiang Y, Hua H. SEPHS1 promotes SMAD2/3/4 expression and hepatocellular carcinoma cells invasion. Exp Hematol Oncol 2021;10:17. [PMID: 33622411 DOI: 10.1186/s40164-021-00212-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Liu YC, Yeh CT, Lin KH. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies. Cells 2020;9:E1331. [PMID: 32466488 DOI: 10.3390/cells9061331] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 9.5] [Reference Citation Analysis]
13 Sai WL, Yao M, Shen SJ, Zheng WJ, Sun JY, Wu MN, Wang L, Yao DF. Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation. Hepatobiliary Pancreat Dis Int 2020;19:449-54. [PMID: 32171652 DOI: 10.1016/j.hbpd.2020.02.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ma J, Li J, Wang Y, Chen W, Zheng P, Chen Y, Sun Z, Liu J, Zhou Y, Wang J, Liu S, Han X. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling. Biomed Pharmacother 2020;121:109617. [PMID: 31810139 DOI: 10.1016/j.biopha.2019.109617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang J, Jiang H, Xu D, Wu WJ, Chen HD, He L. DNA-PKcs Mediates An Epithelial-Mesenchymal Transition Process Promoting Cutaneous Squamous Cell Carcinoma Invasion And Metastasis By Targeting The TGF-β1/Smad Signaling Pathway. Onco Targets Ther 2019;12:9395-405. [PMID: 31807020 DOI: 10.2147/OTT.S205017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Liu Y, Zhou S, Shi J, Zhang X, Shentu L, Chen Z, Zhou L. c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment. Oncogenesis 2019;8:58. [PMID: 31591387 DOI: 10.1038/s41389-019-0166-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
17 Li S, Li J, Yu Z. Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma. Onco Targets Ther 2019;12:5537-44. [PMID: 31371991 DOI: 10.2147/OTT.S196925] [Reference Citation Analysis]
18 Yang X, Wei C, Liu N, Wu F, Chen J, Wang C, Sun Z, Wang Y, Liu L, Zhang X, Wang B, Zhang Y, Zhong H, Han Y, He X. GP73, a novel TGF-β target gene, provides selective regulation on Smad and non-Smad signaling pathways. Biochim Biophys Acta Mol Cell Res 2019;1866:588-97. [PMID: 30615900 DOI: 10.1016/j.bbamcr.2019.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Wang N, Wang S, Li MY, Hu BG, Liu LP, Yang SL, Yang S, Gong Z, Lai PBS, Chen GG. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies. Ther Adv Med Oncol. 2018;10:1758835918816287. [PMID: 30622654 DOI: 10.1177/1758835918816287] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 10.5] [Reference Citation Analysis]
20 De Stefano F, Chacon E, Turcios L, Marti F, Gedaly R. Novel biomarkers in hepatocellular carcinoma. Dig Liver Dis. 2018;50:1115-1123. [PMID: 30217732 DOI: 10.1016/j.dld.2018.08.019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 8.5] [Reference Citation Analysis]
21 Yoshida K, Matsuzaki K, Murata M, Yamaguchi T, Suwa K, Okazaki K. Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis. Cancers (Basel) 2018;10:E183. [PMID: 29874844 DOI: 10.3390/cancers10060183] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]